PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $507,082 | -3.2% | 12,019 | -14.3% | 0.13% | -8.3% |
| Q4 2022 | $523,890 | -66.5% | 14,019 | -52.5% | 0.14% | -67.4% |
| Q3 2022 | $1,566,000 | +17.0% | 29,519 | +27.8% | 0.44% | +24.2% |
| Q2 2022 | $1,339,000 | -60.8% | 23,097 | -50.4% | 0.36% | -56.4% |
| Q1 2022 | $3,413,000 | -84.9% | 46,597 | -87.2% | 0.82% | +24.9% |
| Q4 2021 | $22,609,000 | +2097.2% | 364,376 | +1599.0% | 0.65% | +184.3% |
| Q3 2021 | $1,029,000 | -28.5% | 21,447 | -16.0% | 0.23% | -28.1% |
| Q2 2021 | $1,439,000 | -7.3% | 25,547 | +2.0% | 0.32% | -14.9% |
| Q1 2021 | $1,552,000 | – | 25,047 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |